APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ultrasonic Microbubble Contrast Agents

Compare research editions
View pricing & licenses

Selected research

Industry Research

Ultrasonic Microbubble Contrast Agents Industry Research Report 2026

27 December 2025130 pages

Choose your research edition.

Industry ResearchUltrasonic Microbubble Contrast Agents Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Ultrasonic Microbubble Contrast Agents Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Ultrasonic Microbubble Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ultrasonic Microbubble Contrast Agents Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Ultrasonic Microbubble Contrast Agents Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Ultrasonic Microbubble Contrast Agents market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Ultrasonic Microbubble Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Ultrasonic Microbubble Contrast Agents is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Ultrasonic Microbubble Contrast Agents is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Ultrasonic Microbubble Contrast Agents include Bayer, Bracco, GE Healthcare, ImaRx Therapeutics, Lantheus Medical Imaging, Microvascular Therapeutics, Miltenyi Biotec, NanoPET Pharma and POINTbiomedical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Ultrasonic Microbubble Contrast Agents market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Ultrasonic Microbubble Contrast Agents Market by Company

Bayer

Bracco

GE Healthcare

ImaRx Therapeutics

Lantheus Medical Imaging

Microvascular Therapeutics

Miltenyi Biotec

NanoPET Pharma

POINTbiomedical

Feiruida Medical

Fuman Group

Runkun Pharmaceutical

Lizhuo Pharmaceutical

Qi-hui Biopharmaceutical

SUNΛ Med-Engineering

Starleaf

Ultrasonic Microbubble Contrast Agents Segment by Type

Liposome Envelope

Multimer-based Envelope

Albumin-based Envelope

Others

Ultrasonic Microbubble Contrast Agents Segment by Application

Angiographic Ultrasonography

Cardiac Ultrasonography

Liver Ultrasonography

Others

Ultrasonic Microbubble Contrast Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ultrasonic Microbubble Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ultrasonic Microbubble Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ultrasonic Microbubble Contrast Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Ultrasonic Microbubble Contrast Agents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Ultrasonic Microbubble Contrast Agents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Ultrasonic Microbubble Contrast Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Ultrasonic Microbubble Contrast Agents Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Ultrasonic Microbubble Contrast Agents Sales (Units) of Manufacturers (2021-2026) Table 7. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Manufacturers (2021-2026) Table 8. Global Ultrasonic Microbubble Contrast Agents Revenue of Manufacturers (2021-2026) Table 9. Global Ultrasonic Microbubble Contrast Agents Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Ultrasonic Microbubble Contrast Agents Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Ultrasonic Microbubble Contrast Agents Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Ultrasonic Microbubble Contrast Agents, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Ultrasonic Microbubble Contrast Agents, Product Type & Application Table 14. Global Ultrasonic Microbubble Contrast Agents Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Ultrasonic Microbubble Contrast Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Bayer Company Information Table 19. Bayer Business Overview Table 20. Bayer Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Bayer Ultrasonic Microbubble Contrast Agents Product Portfolio Table 22. Bayer Recent Developments Table 23. Bracco Company Information Table 24. Bracco Business Overview Table 25. Bracco Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Bracco Ultrasonic Microbubble Contrast Agents Product Portfolio Table 27. Bracco Recent Developments Table 28. GE Healthcare Company Information Table 29. GE Healthcare Business Overview Table 30. GE Healthcare Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. GE Healthcare Ultrasonic Microbubble Contrast Agents Product Portfolio Table 32. GE Healthcare Recent Developments Table 33. ImaRx Therapeutics Company Information Table 34. ImaRx Therapeutics Business Overview Table 35. ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolio Table 37. ImaRx Therapeutics Recent Developments Table 38. Lantheus Medical Imaging Company Information Table 39. Lantheus Medical Imaging Business Overview Table 40. Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Product Portfolio Table 42. Lantheus Medical Imaging Recent Developments Table 43. Microvascular Therapeutics Company Information Table 44. Microvascular Therapeutics Business Overview Table 45. Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolio Table 47. Microvascular Therapeutics Recent Developments Table 48. Miltenyi Biotec Company Information Table 49. Miltenyi Biotec Business Overview Table 50. Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Product Portfolio Table 52. Miltenyi Biotec Recent Developments Table 53. NanoPET Pharma Company Information Table 54. NanoPET Pharma Business Overview Table 55. NanoPET Pharma Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. NanoPET Pharma Ultrasonic Microbubble Contrast Agents Product Portfolio Table 57. NanoPET Pharma Recent Developments Table 58. POINTbiomedical Company Information Table 59. POINTbiomedical Business Overview Table 60. POINTbiomedical Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. POINTbiomedical Ultrasonic Microbubble Contrast Agents Product Portfolio Table 62. POINTbiomedical Recent Developments Table 63. Feiruida Medical Company Information Table 64. Feiruida Medical Business Overview Table 65. Feiruida Medical Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Feiruida Medical Ultrasonic Microbubble Contrast Agents Product Portfolio Table 67. Feiruida Medical Recent Developments Table 68. Fuman Group Company Information Table 69. Fuman Group Business Overview Table 70. Fuman Group Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Fuman Group Ultrasonic Microbubble Contrast Agents Product Portfolio Table 72. Fuman Group Recent Developments Table 73. Runkun Pharmaceutical Company Information Table 74. Runkun Pharmaceutical Business Overview Table 75. Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio Table 77. Runkun Pharmaceutical Recent Developments Table 78. Lizhuo Pharmaceutical Company Information Table 79. Lizhuo Pharmaceutical Business Overview Table 80. Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio Table 82. Lizhuo Pharmaceutical Recent Developments Table 83. Qi-hui Biopharmaceutical Company Information Table 84. Qi-hui Biopharmaceutical Business Overview Table 85. Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio Table 87. Qi-hui Biopharmaceutical Recent Developments Table 88. SUNΛ Med-Engineering Company Information Table 89. SUNΛ Med-Engineering Business Overview Table 90. SUNΛ Med-Engineering Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. SUNΛ Med-Engineering Ultrasonic Microbubble Contrast Agents Product Portfolio Table 92. SUNΛ Med-Engineering Recent Developments Table 93. Starleaf Company Information Table 94. Starleaf Business Overview Table 95. Starleaf Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Starleaf Ultrasonic Microbubble Contrast Agents Product Portfolio Table 97. Starleaf Recent Developments Table 98. Global Ultrasonic Microbubble Contrast Agents Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Ultrasonic Microbubble Contrast Agents Sales by Region (2021-2026) & (Units) Table 100. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Region (2021-2026) Table 101. Global Ultrasonic Microbubble Contrast Agents Sales by Region (2027-2032) & (Units) Table 102. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Region (2027-2032) Table 103. Global Ultrasonic Microbubble Contrast Agents Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Region (2021-2026) Table 105. Global Ultrasonic Microbubble Contrast Agents Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Region (2027-2032) Table 107. North America Ultrasonic Microbubble Contrast Agents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026) & (Units) Table 109. North America Ultrasonic Microbubble Contrast Agents Sales by Country (2027-2032) & (Units) Table 110. North America Ultrasonic Microbubble Contrast Agents Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Ultrasonic Microbubble Contrast Agents Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Ultrasonic Microbubble Contrast Agents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026) & (Units) Table 114. Europe Ultrasonic Microbubble Contrast Agents Sales by Country (2027-2032) & (Units) Table 115. Europe Ultrasonic Microbubble Contrast Agents Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Ultrasonic Microbubble Contrast Agents Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Ultrasonic Microbubble Contrast Agents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026) & (Units) Table 119. Asia Pacific Ultrasonic Microbubble Contrast Agents Sales by Country (2027-2032) & (Units) Table 120. Asia Pacific Ultrasonic Microbubble Contrast Agents Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Ultrasonic Microbubble Contrast Agents Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Ultrasonic Microbubble Contrast Agents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026) & (Units) Table 124. South America Ultrasonic Microbubble Contrast Agents Sales by Country (2027-2032) & (Units) Table 125. South America Ultrasonic Microbubble Contrast Agents Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Ultrasonic Microbubble Contrast Agents Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Ultrasonic Microbubble Contrast Agents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026) & (Units) Table 129. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales by Country (2027-2032) & (Units) Table 130. Middle East and Africa Ultrasonic Microbubble Contrast Agents Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Ultrasonic Microbubble Contrast Agents Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (Units) Table 133. Global Ultrasonic Microbubble Contrast Agents Sales by Type (2027-2032) & (Units) Table 134. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Type (2021-2026) Table 135. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Type (2027-2032) Table 136. Global Ultrasonic Microbubble Contrast Agents Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Ultrasonic Microbubble Contrast Agents Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Type (2021-2026) Table 139. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Type (2027-2032) Table 140. Global Ultrasonic Microbubble Contrast Agents Price by Type (2021-2026) & (US$/Unit) Table 141. Global Ultrasonic Microbubble Contrast Agents Price by Type (2027-2032) & (US$/Unit) Table 142. Global Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (Units) Table 143. Global Ultrasonic Microbubble Contrast Agents Sales by Application (2027-2032) & (Units) Table 144. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Application (2021-2026) Table 145. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Application (2027-2032) Table 146. Global Ultrasonic Microbubble Contrast Agents Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Ultrasonic Microbubble Contrast Agents Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Application (2021-2026) Table 149. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Application (2027-2032) Table 150. Global Ultrasonic Microbubble Contrast Agents Price by Application (2021-2026) & (US$/Unit) Table 151. Global Ultrasonic Microbubble Contrast Agents Price by Application (2027-2032) & (US$/Unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Ultrasonic Microbubble Contrast Agents Distributors List Table 155. Ultrasonic Microbubble Contrast Agents Customers List Table 156. Ultrasonic Microbubble Contrast Agents Industry Trends Table 157. Ultrasonic Microbubble Contrast Agents Industry Drivers Table 158. Ultrasonic Microbubble Contrast Agents Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Ultrasonic Microbubble Contrast Agents Product Image Figure 5. Global Ultrasonic Microbubble Contrast Agents Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Ultrasonic Microbubble Contrast Agents Market Size (2021-2032) & (US$ Million) Figure 7. Global Ultrasonic Microbubble Contrast Agents Sales (2021-2032) & (Units) Figure 8. Global Ultrasonic Microbubble Contrast Agents Average Price (US$/Unit) & (2021-2032) Figure 9. Liposome Envelope Product Image Figure 10. Multimer-based Envelope Product Image Figure 11. Albumin-based Envelope Product Image Figure 12. Others Product Image Figure 13. Angiographic Ultrasonography Product Image Figure 14. Cardiac Ultrasonography Product Image Figure 15. Liver Ultrasonography Product Image Figure 16. Others Product Image Figure 17. Global Ultrasonic Microbubble Contrast Agents Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Ultrasonic Microbubble Contrast Agents, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Ultrasonic Microbubble Contrast Agents Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Ultrasonic Microbubble Contrast Agents Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Ultrasonic Microbubble Contrast Agents Sales by Region in 2025 Figure 23. Global Ultrasonic Microbubble Contrast Agents Revenue by Region in 2025 Figure 24. North America Ultrasonic Microbubble Contrast Agents Market Size by Country in 2025 Figure 25. North America Ultrasonic Microbubble Contrast Agents Sales Market Share by Country (2021-2032) Figure 26. North America Ultrasonic Microbubble Contrast Agents Revenue Market Share by Country (2021-2032) Figure 27. United States Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Ultrasonic Microbubble Contrast Agents Market Size by Country in 2025 Figure 31. Europe Ultrasonic Microbubble Contrast Agents Sales Market Share by Country (2021-2032) Figure 32. Europe Ultrasonic Microbubble Contrast Agents Revenue Market Share by Country (2021-2032) Figure 33. Germany Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Ultrasonic Microbubble Contrast Agents Market Size by Country in 2025 Figure 44. Asia Pacific Ultrasonic Microbubble Contrast Agents Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Ultrasonic Microbubble Contrast Agents Revenue Market Share by Country (2021-2032) Figure 46. China Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Ultrasonic Microbubble Contrast Agents Market Size by Country in 2025 Figure 55. South America Ultrasonic Microbubble Contrast Agents Sales Market Share by Country (2021-2032) Figure 56. South America Ultrasonic Microbubble Contrast Agents Revenue Market Share by Country (2021-2032) Figure 57. Brazil Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Ultrasonic Microbubble Contrast Agents Market Size by Country in 2025 Figure 61. Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Ultrasonic Microbubble Contrast Agents Revenue Market Share by Country (2021-2032) Figure 63. Egypt Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Ultrasonic Microbubble Contrast Agents Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Type (2021-2032) Figure 69. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Type (2021-2032) Figure 70. Global Ultrasonic Microbubble Contrast Agents Price (US$/Unit) by Type (2021-2032) Figure 71. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Application (2021-2032) Figure 72. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Application (2021-2032) Figure 73. Global Ultrasonic Microbubble Contrast Agents Price (US$/Unit) by Application (2021-2032) Figure 74. Ultrasonic Microbubble Contrast Agents Value Chain Figure 75. Ultrasonic Microbubble Contrast Agents Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Ultrasonic Microbubble Contrast Agents Industry Opportunities and Challenges

Scope & coverage.

Types
  • Liposome Envelope
  • Multimer-based Envelope
  • Albumin-based Envelope
  • Others
Applications
  • Angiographic Ultrasonography
  • Cardiac Ultrasonography
  • Liver Ultrasonography
  • Others
Companies covered
  • Bayer
  • Bracco
  • GE Healthcare
  • ImaRx Therapeutics
  • Lantheus Medical Imaging
  • Microvascular Therapeutics
  • Miltenyi Biotec
  • NanoPET Pharma
  • POINTbiomedical
  • Feiruida Medical
  • Fuman Group
  • Runkun Pharmaceutical
  • Lizhuo Pharmaceutical
  • Qi-hui Biopharmaceutical
  • SUNΛ Med-Engineering
  • Starleaf

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Ultrasonic Microbubble Contrast Agents Market Size (2021-2032)
  4. 2.2.2 Global Ultrasonic Microbubble Contrast Agents Sales (2021-2032)
  5. 2.2.3 Global Ultrasonic Microbubble Contrast Agents Market Average Price (2021-2032)
  6. 2.3 Ultrasonic Microbubble Contrast Agents by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Liposome Envelope
  9. 2.3.3 Multimer-based Envelope
  10. 2.3.4 Albumin-based Envelope
  11. 2.3.5 Others
  12. 2.4 Ultrasonic Microbubble Contrast Agents by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Angiographic Ultrasonography
  15. 2.4.3 Cardiac Ultrasonography
  16. 2.4.4 Liver Ultrasonography
  17. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Ultrasonic Microbubble Contrast Agents Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Ultrasonic Microbubble Contrast Agents Sales (Units) of Manufacturers (2021-2026)
  3. 3.3 Global Ultrasonic Microbubble Contrast Agents Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Ultrasonic Microbubble Contrast Agents Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Ultrasonic Microbubble Contrast Agents Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Ultrasonic Microbubble Contrast Agents, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Ultrasonic Microbubble Contrast Agents, Product Type & Application
  8. 3.8 Global Manufacturers of Ultrasonic Microbubble Contrast Agents, Established Date
  9. 3.9 Global Ultrasonic Microbubble Contrast Agents Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Bayer
  2. 4.1.1 Bayer Company Information
  3. 4.1.2 Bayer Business Overview
  4. 4.1.3 Bayer Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Bayer Ultrasonic Microbubble Contrast Agents Product Portfolio
  6. 4.1.5 Bayer Recent Developments
  7. 4.2 Bracco
  8. 4.2.1 Bracco Company Information
  9. 4.2.2 Bracco Business Overview
  10. 4.2.3 Bracco Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Bracco Ultrasonic Microbubble Contrast Agents Product Portfolio
  12. 4.2.5 Bracco Recent Developments
  13. 4.3 GE Healthcare
  14. 4.3.1 GE Healthcare Company Information
  15. 4.3.2 GE Healthcare Business Overview
  16. 4.3.3 GE Healthcare Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 GE Healthcare Ultrasonic Microbubble Contrast Agents Product Portfolio
  18. 4.3.5 GE Healthcare Recent Developments
  19. 4.4 ImaRx Therapeutics
  20. 4.4.1 ImaRx Therapeutics Company Information
  21. 4.4.2 ImaRx Therapeutics Business Overview
  22. 4.4.3 ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolio
  24. 4.4.5 ImaRx Therapeutics Recent Developments
  25. 4.5 Lantheus Medical Imaging
  26. 4.5.1 Lantheus Medical Imaging Company Information
  27. 4.5.2 Lantheus Medical Imaging Business Overview
  28. 4.5.3 Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Product Portfolio
  30. 4.5.5 Lantheus Medical Imaging Recent Developments
  31. 4.6 Microvascular Therapeutics
  32. 4.6.1 Microvascular Therapeutics Company Information
  33. 4.6.2 Microvascular Therapeutics Business Overview
  34. 4.6.3 Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolio
  36. 4.6.5 Microvascular Therapeutics Recent Developments
  37. 4.7 Miltenyi Biotec
  38. 4.7.1 Miltenyi Biotec Company Information
  39. 4.7.2 Miltenyi Biotec Business Overview
  40. 4.7.3 Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Product Portfolio
  42. 4.7.5 Miltenyi Biotec Recent Developments
  43. 4.8 NanoPET Pharma
  44. 4.8.1 NanoPET Pharma Company Information
  45. 4.8.2 NanoPET Pharma Business Overview
  46. 4.8.3 NanoPET Pharma Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 NanoPET Pharma Ultrasonic Microbubble Contrast Agents Product Portfolio
  48. 4.8.5 NanoPET Pharma Recent Developments
  49. 4.9 POINTbiomedical
  50. 4.9.1 POINTbiomedical Company Information
  51. 4.9.2 POINTbiomedical Business Overview
  52. 4.9.3 POINTbiomedical Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 POINTbiomedical Ultrasonic Microbubble Contrast Agents Product Portfolio
  54. 4.9.5 POINTbiomedical Recent Developments
  55. 4.10 Feiruida Medical
  56. 4.10.1 Feiruida Medical Company Information
  57. 4.10.2 Feiruida Medical Business Overview
  58. 4.10.3 Feiruida Medical Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Feiruida Medical Ultrasonic Microbubble Contrast Agents Product Portfolio
  60. 4.10.5 Feiruida Medical Recent Developments
  61. 4.11 Fuman Group
  62. 4.11.1 Fuman Group Company Information
  63. 4.11.2 Fuman Group Business Overview
  64. 4.11.3 Fuman Group Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Fuman Group Ultrasonic Microbubble Contrast Agents Product Portfolio
  66. 4.11.5 Fuman Group Recent Developments
  67. 4.12 Runkun Pharmaceutical
  68. 4.12.1 Runkun Pharmaceutical Company Information
  69. 4.12.2 Runkun Pharmaceutical Business Overview
  70. 4.12.3 Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio
  72. 4.12.5 Runkun Pharmaceutical Recent Developments
  73. 4.13 Lizhuo Pharmaceutical
  74. 4.13.1 Lizhuo Pharmaceutical Company Information
  75. 4.13.2 Lizhuo Pharmaceutical Business Overview
  76. 4.13.3 Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio
  78. 4.13.5 Lizhuo Pharmaceutical Recent Developments
  79. 4.14 Qi-hui Biopharmaceutical
  80. 4.14.1 Qi-hui Biopharmaceutical Company Information
  81. 4.14.2 Qi-hui Biopharmaceutical Business Overview
  82. 4.14.3 Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio
  84. 4.14.5 Qi-hui Biopharmaceutical Recent Developments
  85. 4.15 SUNΛ Med-Engineering
  86. 4.15.1 SUNΛ Med-Engineering Company Information
  87. 4.15.2 SUNΛ Med-Engineering Business Overview
  88. 4.15.3 SUNΛ Med-Engineering Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 SUNΛ Med-Engineering Ultrasonic Microbubble Contrast Agents Product Portfolio
  90. 4.15.5 SUNΛ Med-Engineering Recent Developments
  91. 4.16 Starleaf
  92. 4.16.1 Starleaf Company Information
  93. 4.16.2 Starleaf Business Overview
  94. 4.16.3 Starleaf Ultrasonic Microbubble Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Starleaf Ultrasonic Microbubble Contrast Agents Product Portfolio
  96. 4.16.5 Starleaf Recent Developments
5 Global Ultrasonic Microbubble Contrast Agents Market Scenario by Region
  1. 5.1 Global Ultrasonic Microbubble Contrast Agents Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Ultrasonic Microbubble Contrast Agents Sales by Region: 2021-2032
  3. 5.2.1 Global Ultrasonic Microbubble Contrast Agents Sales by Region: 2021-2026
  4. 5.2.2 Global Ultrasonic Microbubble Contrast Agents Sales by Region: 2027-2032
  5. 5.3 Global Ultrasonic Microbubble Contrast Agents Revenue by Region: 2021-2032
  6. 5.3.1 Global Ultrasonic Microbubble Contrast Agents Revenue by Region: 2021-2026
  7. 5.3.2 Global Ultrasonic Microbubble Contrast Agents Revenue by Region: 2027-2032
  8. 5.4 North America Ultrasonic Microbubble Contrast Agents Market Facts & Figures by Country
  9. 5.4.1 North America Ultrasonic Microbubble Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2032)
  11. 5.4.3 North America Ultrasonic Microbubble Contrast Agents Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Ultrasonic Microbubble Contrast Agents Market Facts & Figures by Country
  16. 5.5.1 Europe Ultrasonic Microbubble Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2032)
  18. 5.5.3 Europe Ultrasonic Microbubble Contrast Agents Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Ultrasonic Microbubble Contrast Agents Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Ultrasonic Microbubble Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Ultrasonic Microbubble Contrast Agents Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Ultrasonic Microbubble Contrast Agents Market Facts & Figures by Country
  41. 5.7.1 South America Ultrasonic Microbubble Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2032)
  43. 5.7.3 South America Ultrasonic Microbubble Contrast Agents Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Ultrasonic Microbubble Contrast Agents Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Ultrasonic Microbubble Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Ultrasonic Microbubble Contrast Agents Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2032)
  2. 6.1.1 Global Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2032) & (Units)
  3. 6.1.2 Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Type (2021-2032)
  4. 6.2 Global Ultrasonic Microbubble Contrast Agents Revenue by Type (2021-2032)
  5. 6.2.1 Global Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Ultrasonic Microbubble Contrast Agents Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2032)
  2. 7.1.1 Global Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2032) & (Units)
  3. 7.1.2 Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Application (2021-2032)
  4. 7.2 Global Ultrasonic Microbubble Contrast Agents Revenue by Application (2021-2032)
  5. 7.2.1 Global Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Ultrasonic Microbubble Contrast Agents Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Ultrasonic Microbubble Contrast Agents Value Chain Analysis
  2. 8.1.1 Ultrasonic Microbubble Contrast Agents Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Ultrasonic Microbubble Contrast Agents Production Mode & Process
  5. 8.2 Ultrasonic Microbubble Contrast Agents Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Ultrasonic Microbubble Contrast Agents Distributors
  8. 8.2.3 Ultrasonic Microbubble Contrast Agents Customers
9 Global Ultrasonic Microbubble Contrast Agents Analyzing Market Dynamics
  1. 9.1 Ultrasonic Microbubble Contrast Agents Industry Trends
  2. 9.2 Ultrasonic Microbubble Contrast Agents Industry Drivers
  3. 9.3 Ultrasonic Microbubble Contrast Agents Industry Opportunities and Challenges
  4. 9.4 Ultrasonic Microbubble Contrast Agents Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst